Filter
1088
Text search:
antigen
Featured
Recommendations
150
New Publications
273
Language
Document type
No document type
552
Guidelines
233
Studies & Reports
132
Manuals
55
Fact sheets
47
Strategic & Response Plan
33
Training Material
12
Situation Updates
5
Infographics
5
Brochures
4
Resource Platforms
4
Online Courses
4
Videos
2
Countries / Regions
India
69
Global
44
Germany
38
South Africa
26
Western and Central Europe
24
Africa
24
Nigeria
22
Kenya
22
Uganda
18
Philippines
16
Tanzania
16
Sierra Leone
15
Zambia
15
East and Southern Africa
15
Nepal
13
Ukraine
13
West and Central Africa
13
Latin America and the Carribbean
13
Rwanda
12
Indonesia
12
Liberia
11
Ghana
11
Malawi
11
Russia
11
Ethiopia
10
Zimbabwe
9
Cameroon
8
Namibia
8
Brazil
7
Myanmar / Burma
7
Middle East and North Africa
7
Congo, Democratic Republic of
6
Syria
6
Bangladesh
6
South–East Asia Region
6
Eastern Europe and Central Asia
6
Mozambique
5
USA
4
Cambodia
4
Colombia
4
Lesotho
4
Eastern Europe
4
Saudi Arabia
3
Pakistan
3
Asia
3
Albania
3
Burkina Faso
2
Somalia
2
Iraq
2
Jordan
2
Lebanon
2
Papua New Guinea
2
Sudan
2
Eswatini/ Swaziland
2
Libya
2
Madagascar
2
Iran
2
North America
2
Guinea
1
Senegal
1
Mali
1
Morocco
1
Haiti
1
South Sudan
1
Afghanistan
1
Egypt
1
China
1
Benin
1
Central African Republic
1
Peru
1
North Macedonia
1
Ecuador
1
Botswana
1
Greece
1
Angola
1
Chile
1
Yemen
1
Venezuela
1
Palestine
1
Djibouti
1
Southern Africa
1
Qatar
1
Moldova
1
Kazakhstan
1
Georgia
1
Tunisia
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
409
Clinical Guidelines
156
Pharmacy & Technologies
45
Public Health
35
Women & Child Health
22
Key Resources
19
Capacity Building
8
Toolboxes
COVID-19
206
HIV
128
NTDs
77
TB
71
Rapid Response
70
Ebola
45
Refugee
28
Pharmacy
17
Zika
16
Caregiver
15
Conflict
13
Mental Health
11
AMR
11
Cholera
8
Polio
7
Natural Hazards
6
NCDs
6
Planetary Health
5
Health Financing Toolbox
4
Specific Hazards
3
Global Health Education
3
January 2020 to December 2021
The World Health Organization Regional Office for Africa (WHO AFRO), in accordance with recommendations from various WHO committees, has developed three flagship programmes to support Member States in the African region to prepare for, detect and respond to public health emergencies. They are the re
...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
PLOS One November 20, 2020 https://doi.org/10.1371/journal.pone.0241799 . The first autochthonous case of chikungunya virus (CHIKV) infection in Brazil was in September 2014 in the State of Amapá, and from there it rapidly spread across the country. The present study was conducted in 2016 in the st
...
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector
...
Surveillance Report
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10
...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug
...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat
...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech
...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga
...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la
...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami
...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,
...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t
...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e
...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio
...
Discrete typing units of Trypanosoma cruzi: Geographical and biological distribution in the Americas
Chagas disease caused by Trypanosoma cruzi is a public health issue in Latin America. This highly diverse parasite is divided into at least seven discrete typing units (DTUs) TcI-TcVI and Tcbat. Some DTUs have been associated with geographical distribution in epidemiological scenarios and clinical m
...
Lymphatic filariasis (LF) infection if untreated results in fluid accumulation in the limbs or breasts (lymphedema) or genitalia (hydrocele) that is painful and causes great discomfort. Morbidity management and disability prevention (MMDP) strategies such as surgery for hydrocele, treatment of acute
...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re
...
